Skip to content

PHARMALAW: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARMALAW

BE 0679.616.642
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 compared with 2023filed annual accounts (NBB)
Net result for the year
-€10,079
2023 · -€103,617+€93,538
Equity
€1.2m
2023 · €1.2m-€10,079
Cash
€112,748
2023 · €121,338-€8,590
Balance sheet total
€2.9m
2023 · €3.1m-€176,482

Largest movements

2023 to 2024
Assets
  • Current investments -€250,000

    down €250,000 (-100%), from €250,000 to €0

  • Tangible fixed assets +€238,018

    up €238,018 (+24.8%), from €959,763 to €1.2m

    of which Land and buildings: +€230,056

  • Intangible fixed assets -€159,141

    down €159,141 (-11.3%), from €1.4m to €1.2m

Equity and liabilities
  • Current portion of long-term debt -€129,792

    down €129,792 (-50.2%), from €258,564 to €128,772

  • Trade debts -€43,639

    down €43,639 (-27.8%), from €157,077 to €113,437

Income statement
  • Gross operating margin +€161,485

    up €161,485 (+56.2%), from €287,297 to €448,782

  • Depreciation +€45,476

    up €45,476 (+21.4%), from €212,031 to €257,507

  • Taxes +€23,687

    up €23,687 (+130%), from €18,259 to €41,946

  • Financial charges +€13,626

    up €13,626 (+35.5%), from €38,437 to €52,063

  • Financial income +€9,763

    up €9,763 (+21,141%), from €46 to €9,809

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 -€103,617
Gross operating margin +€161,485
Staff costs +€8,658
Depreciation -€45,476
Other operating charges -€3,578
Financial income +€9,763
Financial charges -€13,626
Taxes -€23,687
Result 2024 -€10,079
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€199,276
Investment -€86,383
Financing -€121,483
Cash 2023 €121,338
Net result for the year -€10,079
Depreciation +€257,507
Stocks and contracts -€17,842
Receivables within one year +€14,367
Deferred charges and accrued income +€245
Trade debts -€43,639
Tax, wage and social debts +€6,215
Other debts -€21,361
Accrued charges and deferred income +€13,864
Investment in fixed assets (net) -€336,383
Current investments +€250,000
Debts after one year +€8,309
Current portion of long-term debt -€129,792
Cash 2024 €112,748
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2023 2024 Change %
Total assets 20/58 €3,081,438 €2,904,955 -€176,482 -5.7%
Fixed assets 21/28 €2,372,156 €2,451,033 +€78,877 +3.3%
Intangible fixed assets 21 €1,402,266 €1,243,125 -€159,141 -11.3%
Tangible fixed assets 22/27 €959,763 €1,197,780 +€238,018 +24.8%
Land and buildings 22 €686,983 €917,039 +€230,056 +33.5%
Plant, machinery and equipment 23 €266,467 €272,309 +€5,842 +2.2%
Furniture and vehicles 24 €6,312 €8,432 +€2,120 +33.6%
Financial fixed assets 28 €10,127 €10,127 = 0.0%
Current assets 29/58 €709,281 €453,922 -€255,359 -36.0%
Stocks and contracts in progress 3 €148,619 €166,462 +€17,842 +12.0%
Stocks 30/36 €148,619 €166,462 +€17,842 +12.0%
Amounts receivable within one year 40/41 €185,898 €171,531 -€14,367 -7.7%
Trade receivables 40 €76,763 €91,374 +€14,611 +19.0%
Other amounts receivable 41 €109,135 €80,157 -€28,977 -26.6%
Current investments 50/53 €250,000 €0 -€250,000 -100%
Cash at bank and in hand 54/58 €121,338 €112,748 -€8,590 -7.1%
Deferred charges and accrued income 490/1 €3,426 €3,181 -€245 -7.1%
Total equity and liabilities 10/49 €3,081,438 €2,904,955 -€176,482 -5.7%
Equity 10/15 €1,177,874 €1,167,795 -€10,079 -0.9%
Contributions 10/11 €6,250 €6,250 = 0.0%
Reserves 13 €16,972 €16,972 = 0.0%
Distributable reserves 133 €16,972 €16,972 = 0.0%
Profit (loss) carried forward 14 €1,154,651 €1,144,573 -€10,079 -0.9%
Amounts payable 17/49 €1,903,564 €1,737,160 -€166,403 -8.7%
Amounts payable after more than one year 17 €1,288,327 €1,296,637 +€8,309 +0.6%
Financial debts 170/4 €1,288,327 €1,295,137 +€6,809 +0.5%
Other amounts payable 178/9 - €1,500 +€1,500
Amounts payable within one year 42/48 €615,236 €426,659 -€188,577 -30.7%
Current portion of amounts payable after more than one year 42 €258,564 €128,772 -€129,792 -50.2%
Trade debts 44 €157,077 €113,437 -€43,639 -27.8%
Suppliers 440/4 €157,077 €113,437 -€43,639 -27.8%
Taxes, remuneration and social security 45 €56,309 €62,525 +€6,215 +11.0%
Taxes 450/3 €28,738 €38,358 +€9,620 +33.5%
Remuneration and social security 454/9 €27,571 €24,167 -€3,404 -12.3%
Other amounts payable 47/48 €143,286 €121,925 -€21,361 -14.9%
Accrued charges and deferred income 492/3 - €13,864 +€13,864
Remuneration, social security and pensions 62 €119,186 €110,528 -€8,658 -7.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €212,031 €257,507 +€45,476 +21.4%
Other operating charges 640/8 €3,048 €6,626 +€3,578 +117%
Gross operating margin 9900 €287,297 €448,782 +€161,485 +56.2%
Operating profit (loss) 9901 -€46,968 €74,122 +€121,089
Financial income 75/76B €46 €9,809 +€9,763 +21,141%
Recurring financial income 75 €46 €9,809 +€9,763 +21,141%
Financial charges 65/66B €38,437 €52,063 +€13,626 +35.5%
Recurring financial charges 65 €38,437 €52,063 +€13,626 +35.5%
Profit (loss) for the period before taxes 9903 -€85,359 €31,867 +€117,226
Income taxes 67/77 €18,259 €41,946 +€23,687 +130%
Profit (loss) for the period 9904 -€103,617 -€10,079 +€93,538 +90.3%
Profit (loss) for the period to be appropriated 9905 -€103,617 -€10,079 +€93,538 +90.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.